cdmo.directory
← Compare landing

ARSI Canada Inc vs LGM Pharma

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/arsicanada/lgmpharma

CategoryARSI Canada IncLGM Pharma
Listed sitebothcdmo
SummaryARSI Canada is a specialized CRO offering custom synthesis, API scale-up, analytical method development, and drug development services with over 50 years of combined experience and a GMP manufacturing facility in Bangladesh.LGM Pharma offers full-service CDMO support from concept through commercialization, plus API sourcing. It provides analytical method development and stability testing for APIs and drug products, with regulatory strategy support for 505(b)(2) and ANDA filings.
Services
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • CMC Analytical Development
  • Analytical Method Development & Validation
  • Process Development
  • Technology Transfer
  • Stability Testing & Storage
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • CMC Analytical Development
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
  • Quality Control Testing
Modalities
  • Small Molecule
  • Small Molecule
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters & R&D, Mississauga, Ontario, Canada
  • GMP Manufacturing, Bangladesh, Bangladesh
Data not yet provided.
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.